A detailed history of Great West Life Assurance CO transactions in Care Dx, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 4,358 shares of CDNA stock, worth $93,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,358
Holding current value
$93,435
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $62,798 - $148,128
4,358 New
4,358 $136,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $49,371 - $79,416
7,053 Added 19.91%
42,479 $297,000
Q2 2023

Aug 10, 2023

BUY
$7.61 - $9.46 $155,594 - $193,419
20,446 Added 136.49%
35,426 $302,000
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $107,169 - $213,732
12,137 Added 426.91%
14,980 $137,000
Q4 2022

Feb 10, 2023

SELL
$10.88 - $20.05 $101,902 - $187,788
-9,366 Reduced 76.71%
2,843 $33,000
Q3 2022

Nov 01, 2022

BUY
$16.06 - $26.39 $196,076 - $322,195
12,209 New
12,209 $208,000
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $28,694 - $47,608
-498 Reduced 14.91%
2,843 $192,000
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $35,339 - $65,757
853 Added 34.28%
3,341 $241,000
Q3 2020

Nov 17, 2020

SELL
$30.88 - $37.94 $543,704 - $668,009
-17,607 Reduced 87.62%
2,488 $94,000
Q3 2020

Nov 13, 2020

BUY
$30.88 - $37.94 $543,704 - $668,009
17,607 Added 707.68%
20,095 $762,000
Q4 2019

Feb 11, 2020

BUY
$19.24 - $28.41 $47,869 - $70,684
2,488 New
2,488 $53,000
Q3 2019

Oct 25, 2019

SELL
$20.03 - $40.08 $72,328 - $144,728
-3,611 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$25.78 - $39.77 $7,373 - $11,374
286 Added 8.6%
3,611 $0
Q4 2018

Feb 12, 2019

BUY
$19.89 - $30.02 $66,134 - $99,816
3,325 New
3,325 $81,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.